Search Results - "Morris, S. B."

Refine Results
  1. 1

    Indirect bioequivalence assessment using network meta-analyses by Ring, A., Morris, T. B. S., Hohl, K., Schall, R.

    Published in European journal of clinical pharmacology (01-08-2014)
    “…Aims For market approval, new drug formulations (test) must demonstrate bioequivalence (BE) to at least one approved formulation (reference). If several…”
    Get full text
    Journal Article
  2. 2

    Chest wall tuberculosis: a review of CT appearances by MORRIS, B. S, MAHESHWARI, M, CHALWA, A

    Published in British journal of radiology (01-05-2004)
    “…Tuberculous abscesses of the chest wall, though uncommon are not infrequently encountered in countries endemic to the disease. This pictorial review of 14…”
    Get full text
    Journal Article
  3. 3

    The CT appearances of gallbladder perforation by MORRIS, B. S, BALPANDE, P. R, MORANI, A. C, CHAUDHARY, R. K, MAHESHWARI, M, RAUT, A. A

    Published in British journal of radiology (01-11-2007)
    “…Perforation of the gallbladder is an uncommon complication of acute cholecystitis that is associated with relatively high mortality. Symptoms and clinical…”
    Get full text
    Journal Article
  4. 4

    The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis by Keane, MP, Arenberg, DA, Lynch, JP, 3rd, Whyte, RI, Iannettoni, MD, Burdick, MD, Wilke, CA, Morris, SB, Glass, MC, DiGiovine, B, Kunkel, SL, Strieter, RM

    Published in The Journal of immunology (1950) (01-08-1997)
    “…Idiopathic pulmonary fibrosis (IPF) is a chronic and often fatal disorder. Fibroplasia and deposition of extracellular matrix are dependent, in part, on…”
    Get full text
    Journal Article
  5. 5

    Distribution of the standardized mean change effect size for meta-analysis on repeated measures by Morris, Scott B.

    “…When conducting a meta‐analysis on studies with repeated measures, a useful measure of effect size is Becker's (1988) standardized mean change. This paper…”
    Get full text
    Journal Article
  6. 6

    Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer by Arenberg, D A, Keane, M P, DiGiovine, B, Kunkel, S L, Morris, S B, Xue, Y Y, Burdick, M D, Glass, M C, Iannettoni, M D, Strieter, R M

    Published in The Journal of clinical investigation (01-08-1998)
    “…We report here the role of the CXC chemokine, epithelial neutrophil activating peptide (ENA-78), as an angiogenic factor in human non-small cell lung cancer…”
    Get full text
    Journal Article
  7. 7

    Latent tuberculous infection testing among HIV-infected persons in clinical care, United States, 2010-2012 by Reaves, E. J., Shah, N. S., France, A. M., Morris, S. B., Kammerer, S., Skarbinski, J., Bradley, H.

    “…SETTING: Current guidelines recommend latent tuberculous infection (LTBI) testing at the time of human immunodeficiency virus (HIV) diagnosis and annually…”
    Get full text
    Journal Article
  8. 8

    Distinct CXC Chemokines Mediate Tumorigenicity of Prostate Cancer Cells by Moore, Bethany B., Arenberg, Douglas A., Stoy, Kevin, Morgan, Tamara, Addison, Christina L., Morris, Susan B., Glass, Mary, Wilke, Carol, Xue, Ying Ying, Sitterding, Stephanie, Kunkel, Steven L., Burdick, Marie D., Strieter, Robert M.

    Published in The American journal of pathology (01-05-1999)
    “…Prostate cancer is the second leading cause of malignancy-related mortality in males in the United States. As a solid tumor, clinically significant tumor…”
    Get full text
    Journal Article
  9. 9

    The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis by Addison, C L, Arenberg, D A, Morris, S B, Xue, Y Y, Burdick, M D, Mulligan, M S, Iannettoni, M D, Strieter, R M

    Published in Human gene therapy (20-01-2000)
    “…Angiogenesis is an absolute requirement for tumor growth beyond 2 mm3 in size. The balance in expression between opposing angiogenic and angiostatic factors…”
    Get more information
    Journal Article
  10. 10

    Blood-fluid levels in the brain by MORRIS, B. S, NAGAR, A. M, MORANI, A. C, CHAUDHARY, R. K, GARG, P. A, CHUDGAR, P. D, RAUT, A. A

    Published in British journal of radiology (01-06-2007)
    “…17 cases reviewed prospectively over a period of 4 months highlight the varied appearance of blood-fluid levels in intracranial cystic lesions of different…”
    Get full text
    Journal Article
  11. 11

    High-intensity focused ultrasound ablation of the kidney in a large animal model by Watkin, N A, Morris, S B, Rivens, I H, ter Haar, G R

    Published in Journal of endourology (01-06-1997)
    “…The purpose of this study was to establish the feasibility of noninvasive treatment of small renal tumors with high-intensity focused ultrasound (HIFU). A…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Correcting Effect Sizes Computed From Factorial Analysis of Variance for Use in Meta-Analysis by Morris, Scott B, DeShon, Richard P

    Published in Psychological methods (01-06-1997)
    “…In meta-analysis, it is possible to average results across multiple studies because the effect sizes estimated from each study are in the same metric (e.g.,…”
    Get full text
    Journal Article
  14. 14

    Sublethal Hyperoxia Impairs Pulmonary Innate Immunity by Baleeiro, Carlos E. O, Wilcoxen, Steven E, Morris, Susan B, Standiford, Theodore J, Paine, Robert, III

    Published in The Journal of immunology (1950) (15-07-2003)
    “…Supplemental oxygen is often required in the treatment of critically ill patients. The impact of hyperoxia on pulmonary host defense is not well-established…”
    Get full text
    Journal Article
  15. 15

    A feasibility study for the non-invasive treatment of superficial bladder tumours with focused ultrasound by Watkin, N A, Morris, S B, Rivens, I H, Woodhouse, C R, ter Haar, G R

    Published in British journal of urology (01-11-1996)
    “…To determine whether high-intensity focused ultrasound can be used to ablate bladder wall tissue using a transabdominal approach in a large animal model, and…”
    Get more information
    Journal Article
  16. 16

    Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases by Arenberg, D A, Kunkel, S L, Polverini, P J, Morris, S B, Burdick, M D, Glass, M C, Taub, D T, Iannettoni, M D, Whyte, R I, Strieter, R M

    Published in The Journal of experimental medicine (01-09-1996)
    “…The success of solid tumor growth and metastasis is dependent upon angiogenesis. Neovascularization within the tumor is regulated, in part, by a dual and…”
    Get full text
    Journal Article
  17. 17

    Raju's Differential Functioning of Items and Tests (DFIT) by Oshima, T. C., Morris, S. B.

    “…Nambury S. Raju (1937–2005) developed two model‐based indices for differential item functioning (DIF) during his prolific career in psychometrics. Both…”
    Get full text
    Journal Article
  18. 18

    Granulocyte-Macrophage Colony-Stimulating Factor in the Innate Immune Response to Pneumocystis carinii Pneumonia in Mice by Paine, Robert, III, Preston, Angela M, Wilcoxen, Steven, Jin, Hong, Siu, Brian B, Morris, Susan B, Reed, Jacquelyn A, Ross, Gary, Whitsett, Jeffrey A, Beck, James M

    Published in The Journal of immunology (1950) (01-03-2000)
    “…Innate immunity plays an important role in pulmonary host defense against Pneumocystis carinii, an important pathogen in individuals with impaired…”
    Get full text
    Journal Article
  19. 19

    Superficial bladder cancer: for how long should a tumour-free patient have check cystoscopies? by Morris, S B, Gordon, E M, Shearer, R J, Woodhouse, C R

    Published in British journal of urology (01-02-1995)
    “…To determine the probability of a patient with superficial bladder cancer developing a recurrent tumour after having remained tumour free for 2 or more years…”
    Get more information
    Journal Article
  20. 20

    Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice by Paine, 3rd, R, Morris, S B, Jin, H, Wilcoxen, S E, Phare, S M, Moore, B B, Coffey, M J, Toews, G B

    “…We hypothesized that pulmonary granulocyte-macrophage colony-stimulating factor (GM-CSF) is critically involved in determining the functional capabilities of…”
    Get more information
    Journal Article